Small dense LDL-1 (sdLDL-1) is the first of the small dense LDL subfractions — particles that are smaller and denser than standard LDL. Small dense LDL particles are more atherogenic than large LDL for several reasons: they penetrate arterial walls more easily, they are more susceptible to oxidation, they have a longer half-life in the circulation, and they have reduced affinity for LDL receptors.
Elevated sdLDL particles are a hallmark of the atherogenic dyslipidaemia associated with insulin resistance, metabolic syndrome, type 2 diabetes, and high triglycerides. sdLDL-1 is the largest of the small dense particles — still dangerous but less so than sdLDL-4 through 7. Its elevation alongside other small dense particles indicates a shift toward Pattern B lipid phenotype.
FAQs
Why are small dense LDL particles more dangerous than large LDL?
Small dense particles penetrate arterial walls more easily, oxidise more readily, have reduced LDL receptor affinity (so they circulate longer), and accumulate in plaques more efficiently than large buoyant LDL.
Is sdLDL routinely tested?
No. Small dense LDL subfraction analysis is available through specialised cardiovascular risk assessment, not standard lipid panels.
How do I shift from Pattern B to Pattern A?
Reducing refined carbohydrates and sugars, exercising, losing weight, and adopting a Mediterranean diet consistently shift the LDL particle distribution toward larger, less atherogenic particles.
Do statins reduce small dense LDL?
Statins reduce total LDL particle number including small dense particles, but do not specifically shift the size distribution. Fibrates and dietary carbohydrate restriction are more specific for improving particle size.
